New clinical and molecular insights on Barth syndrome

Table 1 Oligonucleotides used for TAZ gene mutation analysis

Fragment name	Primer	Sequence 5’-3’	Included exons	Amplified gene region*	Length (bp)
Taz 1-2	Taz 1-2fw	agtcaggggccagtgtctc	1 and 2	g.5224_5736	552
Taz 1-2	Taz 1-2rv	gaaggggtttgttctgacga	1 and 2	g.5224_5736	552
Taz 3-4	Taz 3-4fw	ctggggatatgggaagttgg	3 and 4	g.6642_7095	494
Taz 3-4	Taz 3-4rv	ccataggtccctccaaaaca	3 and 4	g.6642_7095	494
Taz 5	Taz 5fw	aaggtcatggggtaggaggt	5	g.7519_7714	236
Taz 5	Taz 5rv	aaactcctgggcttgagtga	5	g.7519_7714	236
Taz 6-7	Taz 6-7fw	ccccgagaatggttactgat	6 and 7	g.12983_13340	398
Taz 6-7	Taz 6-7rv	aggcctagtctcagcacctg	6 and 7	g.12983_13340	398
Taz 8-9	Taz 8-9fw	gggagctgaattgaactgga	8 and 9	g.13404_13753	390
Taz 8-9	Taz 8-9rv	agacagcagacaggcagaca	8 and 9	g.13404_13753	390
Taz 10-11	Taz 10-11fw	ggcactcctactgctcctca	10 and 11	g.14097_14513	457
Taz 10-11	Taz 10-11rv	agcatcagtccatccctcag	10 and 11	g.14097_14513	457

*based upon the reference nucleotide sequence NG_009634.1. Positions do not include the primer sequences.

ISSN: 1750-1172